tapebrief
MCHP · Q2 2026
MCHP · Q4 2026

MCHP · Q3 2026 Earnings

Bullish

Microchip Technology

Reported February 5, 2026

30-second summary

Microchip beat its own December guide on every line — revenue $1.186B ($37M above the high end), non-GAAP EPS $0.44 ($0.04 above the high end), gross margin 60.5% (+130bps above the high end), operating margin 28.5% (+160bps above the high end) — and guided March to $1.26B at midpoint, +6.2% QoQ and +29.8% YoY. The "three strong quarters" narrative that management walked back 90 days ago is now back on the table with materially harder numbers underneath it: distribution inventory is "largely corrected," gross margin hit a 60-handle a quarter earlier than promised, and bookings continue to grow into a backlog that's "substantially better" than December's starting point.

Headline numbers

EPS

Q3 FY2026

$0.44

Revenue

Q3 FY2026

$1.19B

+15.6% YoY

Gross margin

Q3 FY2026

60.5%

Free cash flow

Q3 FY2026

$0.32B

Operating margin

Q3 FY2026

28.5%

Key financials

Q3 FY2026
MetricQ3 FY2026YoYQ2 FY2026QoQ
Revenue$1.19B+15.6%$1.14B+4.0%
EPS$0.44—$0.35+25.7%
Gross margin60.5%—56.7%+380bps
Operating margin28.5%—24.3%+420bps
Free cash flow$0.32B—$0.05B+513.3%

Guidance

Strong Q3 beat across revenue, EPS, and margins; company raises Q4 guidance with 30% YoY growth and margin expansion continuing.

Guidance is issued for both next quarter and the full year. Both may appear below.

Actuals vs prior guidance

MetricPeriodPrior guideActualΔResult
RevenueQ3 FY2026$1.109B to $1.149B$1.186B+$0.037B above the high end of guideBeat
Non-GAAP EPSQ3 FY2026$0.34 to $0.40$0.44+$0.04 above the high end of guideBeat
Non-GAAP Gross MarginQ3 FY202657.2% to 59.2%60.5%+1.3pts above the high end of guideBeat
Non-GAAP Operating MarginQ3 FY202624.5% to 26.9%28.5%+1.6pts above the high end of guideBeat
Sequential Revenue GrowthQ3 FY2026expected to be 'stronger than a seasonal low single digit up sequentially'4.0%in-lineMet

New guidance

MetricPeriodGuideYoY
Non-GAAP EPSQ4 FY2026$0.48 to $0.52—
RevenueQ4 FY2026$1.24B to $1.28B29.8%
Non-GAAP Gross MarginQ4 FY202660.5% to 61.5%—
Non-GAAP Operating MarginQ4 FY202628.8% to 30.2%—

Capacity & utilization

Q3 FY2026
SegmentQ3 FY2026
YoY Revenue Growth15.6%
Sequential Revenue Growth4.0%
Inventory Reduction ProgressSubstantial progress on inventory normalization

Profitability

Q3 FY2026
SegmentQ3 FY2026
Gross Margin (Non-GAAP)60.5%
Operating Margin (Non-GAAP)28.5%
Free Cash Flow Margin26.9%
Operating Cash Flow$341.4M
Net Debt Reduction$26M reduced in quarter

Management tone

Defensive restructuring → recovery mechanics → broken seasonality promise → recovery vindicated.

Three quarters ago management was framing the cycle bottom around fab shutdowns, pay cuts, and dividend defense; last quarter the recovery narrative fractured on a -1% December guide and analysts pressed on whether the "above-seasonal across three quarters" claim still held; this quarter management has delivered the harder evidence the credibility test required. The anchor: "distribution inventory has largely corrected" — the $11.7M sell-in vs. sell-through gap (down from $52.9M) is the cleanest signal in three quarters that the channel headwind has actually ended rather than just narrowed. The signal: the recovery story now rests on demand normalization rather than channel mechanics, which is a structurally stronger footing.

The gross margin framing has shifted from defensive bifurcation to executed delivery. Last quarter management was steering analysts to the 67.4% "product gross margin" underneath ~10.8 points of inventory and underutilization charges, asking investors to look through the optical number. This quarter: "We had been expecting a sixth handle on non-GAAP gross margin percentage in the March quarter, but we achieved it a quarter earlier." The 60.5% print is the reported number, not a reconciled one. The bifurcated narrative that was load-bearing last quarter has become unnecessary — the mathematical inflection point management mapped out (YoY sales growth turning positive mechanically shrinks charges) actually happened, with +15.6% YoY printed.

The data center and connectivity commentary has hardened from "well-positioned" claims to specific design wins. Last quarter Gen6 was described as "the only 3-nanometer-based device currently sampling" with production revenue starting June 2026; this quarter management disclosed three Gen6 design wins, has Gen7 research underway, and announced a named platform commitment with Hyundai for T1S automotive Ethernet — "a strategic collaboration with Hyundai Motor Group to integrate our Tempest T1S solutions into next-generation vehicle platforms." The pattern across three quarters — emerging opportunity → exclusivity claim → named customer with platform commitment — is the trajectory bulls have been pricing.

Supply commentary has reversed in a notable direction. Two quarters ago lead times were "stable at 4–8 weeks with ample capacity"; last quarter they were "bouncing off the bottom" with "isolated" constraints; this quarter management said constraints "were isolated to specific areas but are now starting to spread more broadly." This is the first explicit acknowledgement that the supply environment is tightening across multiple categories. It cuts both ways: pricing power and customer-priority-shifting (away from price toward availability, per the Goldman exchange) are bullish; but the same dynamic raises the PSP-repeat tail risk if customers start placing speculative orders, and could constrain the slope of growth into June and September.

Recurring themes management leaned on this quarter:

Inventory normalization at distributors and customersMargin expansion ahead of guidancePCIe Gen6 market leadership with three design winsAutomotive Ethernet (T1S) modernization cycle gaining momentumIndustrial 4.0 connectivity opportunitySupply chain constraints re-emerging on substrates and foundry nodes

Risks management surfaced:

Substrate supply constraints starting to spread more broadlySubcontracting capacity challengesAdvanced node foundry constraintsLead time increases on certain productsCompetition in PCIe and connectivity markets

Q&A highlights

Matthew Prisco · Cantor Fitzgerald

What drives confidence in above-seasonal March guidance and growth beyond as the sell-in vs. sell-through gap closes? Is it better end demand, restocking, or idiosyncratic opportunities?

Management attributes confidence to strong backlog and bookings that continue to grow. Direct customers and distributor customers are still burning through inventory. Lead times remain short, limiting visibility beyond current quarter, but order book is growing. June and September quarters historically strongest, and company is well-positioned for growth.

Distribution inventory correction largely completeStrong backlog for current quarter with continuing growthLead times still short, limiting visibility beyond Q1June and September quarters are seasonally strongest

Vivek Arya · Bank of America Securities

What drove December upside vs. original guidance—was it product segments or the 'other' segment? How should March quarter be modeled across product segments vs. other?

Licensing upside was modeled originally; actual upside came from products (microcontrollers, analog, FPGA) being substantially stronger than expected, reversing typical seasonal decline. March guidance of 6.2% sequential (vs. typical 2-3%) reflects strong backlog and positive momentum across most product lines despite customers pulling March orders into December.

December guidance was 11-29, actual was 11-86 (57bp upside)December typically down 3-5%; microcontroller and analog were flatFPGA and other product lines also substantially strongerMarch guidance 6.2% sequential despite typical seasonality of 2-3%

Jim Snyder · Goldman Sachs

Are customers restocking their own internal inventories? Are there signs of restock across specific verticals or still in reduction mode?

Not yet seeing broad customer restocking behavior. Customers are still drawing down inventory accumulated 1-2 years ago (some had year-long supply). As inventory normalizes per SKU, customers move to consumption-rate buying. Expedite requests have grown exponentially. Capacity tightening is beginning; foundry processes filling up. Restocking would require lead times to tighten further; currently lead times in check but constraints broadening.

No broad restocking phenomenon yetCustomers historically had up to 1 year of inventory; still normalizingExpedite requests exponentially higher than quarters agoGeneric foundry processes now full

Blaine Curtis · Jefferies

Can you add color on the 18% sequential growth in 'other' product revenue attributed to licensing? Will that repeat into March? Also, what's driving strength in memory business?

Other includes licensing, FPGA, memory, and timing systems. Memory is experiencing strength due to high bandwidth memory and NAND/flash scarcity; competitors moving serial EEPROM capacity to broader flash, creating share gains for Microchip. Serial EEPROM produced in internal fabs where Microchip has capacity and inventory advantage. Not expecting licensing repeat in March, yet still guiding 6.2% sequential growth. Memory and FPGA backlog both strong for March and June.

Other segment includes licensing, FPGA, memory, timing systemsMemory shortage is couple-year phenomenonCompetitors shifting serial EEPROM capacity to flash memoryMicrochip serial EEPROM produced internally with available capacity

Joe Moore · Morgan Stanley

What growth rate and market share trends are you seeing in FPGA? Also on PCI Express Gen 6: are design wins scale-up or scale-out applications, and what's the roadmap for Gen 7 and other protocols to maintain revenue momentum?

FPGA seeing very large growth and gaining market share versus Xilinx/AMD and private Altera; specific numbers withheld to avoid competitor benefit; may provide bracketed numbers post-fiscal year. Gen 6 PCIe has significant runway; Gen 7 research underway for ~9-12 months. Multiple customer engagements in design phase with three design wins announced; pursuing mega design wins. Customer identity and scale-up vs. scale-out details withheld due to competitive sensitivity.

FPGA experiencing very large growth with market share gainsBracketed FPGA numbers may be provided post-fiscal yearGen 6 PCIe in design phase with customersThree PCIe Gen 6 design wins announced

Answers to last quarter's watch list

March quarter sequential growth above 5% — March guide is +6.2% at midpoint, clearing the 5% threshold. The "above-seasonal across three consecutive quarters" claim that fractured last quarter is back on the table with a harder number underneath it.
Resolved positively
Sell-in vs. sell-through gap finally closing below $30M — Gap closed to $11.7M from $52.9M, a $41M sequential improvement and well inside the threshold. Distribution inventory has "largely corrected.".
Resolved positively
Q3 adjusted FCF vs. dividend coverage — Reported FCF was $318.9M and operating cash flow $341.4M; the company reduced net debt by $26M in the quarter, which mechanically implies the dividend was internally funded with room to pay down debt. The "stop borrowing to fund the dividend" commitment held.
Resolved positively
Inventory charges declining materially from $122.8M — Reported gross margin of 60.5% vs. last quarter's 56.7% reflects +379bps of margin recovery (per management), consistent with materially lower inventory and underutilization charges. The bifurcated narrative is no longer needed — the reported number is now the headline number. Specific charge figure not separately disclosed in the press release.
Resolved positively
Gen 6 PCIe switch design-win disclosure or customer naming — Three Gen6 design wins announced this quarter; specific hyperscaler customer identities withheld for competitive reasons. Progress is meaningful but full customer naming did not happen.
Resolved positively
Whether emerging substrate and advanced-node supply constraints broaden — Management explicitly said constraints "were isolated to specific areas but are now starting to spread more broadly." Substrates, subcontracting, and advanced-node foundry all flagged. Customers' purchasing focus is shifting from price to availability, per the Goldman exchange.
Resolved negatively

What to watch into next quarter

March revenue print at or above the $1.26B midpoint — anything below the low end ($1.24B) breaks the +29.8% YoY narrative and re-opens the credibility question on the "three strong quarters" thesis.

June quarter sequential guide ≥5% — the historical seasonally strongest quarter; a soft June guide (below 5% sequential) after a +6.2% March guide would signal the recovery slope is flattening earlier than expected.

Gross margin reaches 61.5% (high end of March guide) and progress toward 65% long-term target — the recovery thesis now rests on continued margin expansion driven by mix and utilization, not channel correction. A March print at the low end (60.5%, flat to December) would suggest the easy recovery gains are behind.

PCIe Gen6 production revenue commentary and additional design-win disclosure — three design wins is a strong start; specific hyperscaler naming or bracketed Gen6 revenue figures post-fiscal year would validate the "beating competitors in virtually every specification metric" claim. Continued silence into June 2026 production ramp would suggest competitive positioning is less differentiated than advertised.

Whether substrate and foundry constraints force price increases or backlog stretches — management framed broadening constraints as a pricing-power positive, but the same dynamic creates PSP-repeat tail risk. Watch for any acknowledgement of speculative ordering, lead-time extensions beyond 12 weeks broadly, or order cancellability changes.

Adjusted FCF coverage of dividend at run-rate — Q3 FCF of $318.9M clearly covered the ~$246.1M dividend. Whether Q4 sustains coverage without seasonal benefit confirms the "no more borrowing to fund the dividend" message is durable rather than a one-quarter inflection.

Sources

  1. Microchip Technology Q3 FY2026 press release, exhibit 99.1, filed via SEC EDGAR — https://www.sec.gov/Archives/edgar/data/827054/000082705426000008/exhibit991q3fy26.htm
  2. Q&A content drawn from analyst-call exchanges referenced in extraction inputs (Matthew Prisco/Cantor Fitzgerald, Vivek Arya/Bank of America, Jim Snyder/Goldman Sachs, Blaine Curtis/Jefferies, Joe Moore/Morgan Stanley).

Get the next brief, free.

We publish analyst-grade earnings briefs the same day or morning after every call — headline numbers, segment KPIs, Q&A highlights, and tone analysis. Free during beta.

This is not investment advice.